Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells
Stopped study was stopped due to funding issues
Conditions
Interventions
- OTHER: autologous CD133pos stem cell application
Sponsor
Asklepios proresearch
Collaborators